pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
cetrelimab
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
Programmed cell death protein 1
$JNJJOHNSON & JOHNSON
0 catalysts
Marketed
cetuximab
Erbitux (cetuximab)
Head And Neck Squamous Cell Carcinoma (HNSC)
Eli Lilly Interamerica Inc
0 catalysts
Phase 3
cetuximab sarotalocan
Recurrent Head And Neck Squamous Cell Carcinoma
Epidermal growth factor receptor
← prev
page 43 of 62
next →
131
Pain89
Neurology1
Rakuten Medical Inc
0 catalysts
Phase 2
cevostamab
Refractory Multiple Myeloma
Genentech Inc
0 catalysts
Marketed
chlorambucil
Leukeran (chlorambucil [INN])
Chronic Lymphocytic Leukemia (CLL)
GlaxoSmithKline LLC
0 catalysts
Preclinical
chrysoeriol
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Flavocure Biotech Inc
0 catalysts
Phase 2
ciforadenant
Renal Cell Carcinoma
Adenosine receptor A2a
$CRVSCorvus Pharmaceuticals, Inc.
0 catalysts
Marketed
ciltacabtagene autoleucel
Carvykti (ciltacabtagene autoleucel)
Refractory Multiple Myeloma
Janssen Biotech Inc
0 catalysts
Phase 2
ciltistotug
Metastatic Melanoma
Eucure (Beijing) Biopharma Co Ltd
0 catalysts
Marketed
cimetidine
Cimetidine (cimetidine)
Acid Indigestion (Heartburn/Pyrosis)
L. Perrigo Company
0 catalysts
Marketed
cimetidine hydrochloride
Cimetidine Hydrochloride (cimetidine hydrochloride)
Duodenal Ulcer
Chartwell Pharmaceuticals LLC
0 catalysts
Phase 3
cintredekin besudotox
Glioblastoma Multiforme (GBM)
Interleukin 13 receptorInterleukin-13 receptor subunit alpha-2
Precision Neuromed Inc
0 catalysts
Preclinical
clofarabine
Clofarabine Winthrop (clofarabine)
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
BoYen Therapeutics Inc
0 catalysts
Marketed
cobimetinib fumarate
Cotellic (cobimetinib fumarate)
Erdheim-Chester Disease (Erdheim–Chester Syndrome/ Polyostotic Sclerosing His…
Genentech Inc
0 catalysts
Marketed
copanlisib hydrochloride
Aliqopa (copanlisib hydrochloride)
Follicular Lymphoma
Bayer HealthCare Pharmaceuticals Inc
0 catalysts
Phase 3
crenolanib besylate
Refractory Acute Myeloid Leukemia
Arog Pharmaceuticals Inc
0 catalysts
Phase 3
cretostimogene grenadenorepvec
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
$CGONCG Oncology, Inc.
0 catalysts
Marketed
crizotinib
Xalkori (crizotinib)
Anaplastic Large Cell Lymphoma (ALCL)
EML4-ALKNPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor)
$PFEPFIZER INC
0 catalysts
Phase 2
cusatuzumab
cusatuzumab [INN]
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
OncoVerity Inc
0 catalysts
Marketed
cytarabine
Cytarabine (cytarabine)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Meitheal Pharmaceuticals Inc
0 catalysts
Phase 2
dabogratinib
dabogratinib [INN]
Achondroplasia
$TYRATyra Biosciences, Inc.
0 catalysts
Marketed
dabrafenib mesylate + trametinib dimethyl sulfoxide
Tafinlar + Mekinist (dabrafenib mesylate + trametinib dimethyl sulfoxide)
Anaplastic Thyroid Cancer
$NVSNOVARTIS AG
0 catalysts
Marketed
dacarbazine
Dacarbazine (dacarbazine)
Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma)
Meitheal Pharmaceuticals Inc
0 catalysts
Marketed
dacomitinib
Vizimpro (dacomitinib)
Non-Small Cell Lung Cancer
$PFEPFIZER INC
0 catalysts
Marketed
dactinomycin
Dactinomycin (dactinomycin)
Choriocarcinoma (Gestational Trophoblastic Neoplasia)
Hisun Pharmaceutical USA Inc
0 catalysts
pre_registration
daratumumab
Darzalex (daratumumab)
Multiple Myeloma (Kahler Disease)
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1
$JNJJOHNSON & JOHNSON
0 catalysts
Phase 2
daretabart
daretabart [INN]
Neuroblastoma
Essential Holdings Ltd
0 catalysts
Phase 2
darinaparsin
Peripheral T-Cell Lymphomas (PTCL)
Solasia Pharma KK
0 catalysts
Phase 1
darlifarnib
darlifarnib [INN]
Head And Neck Squamous Cell Carcinoma (HNSC)
$KURAKura Oncology, Inc.
0 catalysts
Marketed
darolutamide
Nubeqa (darolutamide)
Castration-Resistant Prostate Cancer (CRPC)
Bayer HealthCare Pharmaceuticals Inc
0 catalysts